OGTT-CGMHome Glucose Tolerance Test Using Continuous Glucose Monitoring for Prediabetes
OGTT at home using CGM
+ OGTT at the clinic
Diabetes Mellitus+4
+ Endocrine System Diseases
+ Hyperglycemia
Diagnostic Study
Summary
Study start date: June 11, 2025
Actual date on which the first participant was enrolled.This study examines an innovative way to perform an oral glucose tolerance test (OGTT) at home for people with prediabetes. It compares doing the test at home using a continuous glucose monitor (CGM) with the traditional method done in a clinic. By making testing more accessible and less burdensome, the study aims to see if this home method can provide results as reliable as the clinic tests. The goal is to see if home testing can help in early detection of issues with blood sugar levels, potentially leading to better management of prediabetes. Participants in the study will be split into two groups. One group will start with a clinic-based OGTT, while the other will begin with the home-based OGTT. Each participant will experience both methods. During the home test, a CGM will track glucose levels continuously, while the clinic test will use blood samples. The study will measure how closely the results from the home method match those from the clinic method, look at how glucose levels vary between the two tests, and evaluate how practical and comfortable home testing is for participants. This approach might offer a more convenient way to monitor glucose tolerance without frequent clinic visits.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.75 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Diagnostic Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 70 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalGroup II
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 3 locations
Primary Health Care Center Bra Liv Rosenhälsan
Huskvarna, SwedenOpen Primary Health Care Center Bra Liv Rosenhälsan in Google MapsPrimary Health Care Center Cityhälsan Centrum
Norrköping, SwedenPrimary Care Center Vårdcentralen Kärna
Linköping, Sweden